Europe Protein A Resin Market: By Product Type (Natural Protein A Resin and Recombinant Protein A Resin), By Matrix Type (Glass or Silica, Agarose, and Organic Polymer), By Application (Immunoprecipitation (IP) and Antibody Purification), By End User (Biopharmaceutical Companies, Clinical Research Laboratories, and Academic Institutes), and Country (Germany, France, U.K, Italy, Spain, Russia, Poland, and Rest of Europe) - Market Estimation, Dynamics, Country Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

October 2017 | 104 pages | ID: E3D2FB1936DEN
Precision Business Insights (PBI)

Abstracts

Europe Protein A Resin Market Report Description:

Europe Protein A Resin market report gives comprehensive outlook on protein a resin usage across the regions with special emphasis on key countries such as Germany, France, U.K, Italy, Spain, Russia, and Poland. The report on Protein A Resin market gives historical, current, and future market sizes (US$ Mn) on the basis of device type, application, end users, and country. Europe Protein A Resin market report presents the market dynamics elaborately to identify the current market trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, Europe Protein A Resin market report includes the competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed Europe Protein A Resin market to better equip clients with possible investment opportunities across the countries (Country Investment Hot-Spots) and market unmet needs. Key stakeholders of the Europe Protein A Resin market report include component suppliers, manufacturers, marketers, hospitals, physician offices, policy makers, and healthcare service providers, who are engaged in usage and advocacy of Protein A Resin.

Europe Protein A Resin Market:

Europe Protein A Resin market was valued around US$ 110 Mn in 2016 and poised to grow around 9.0% CAGR over 2017-2023.

COMPETITION ASSESSMENT

Key players profiles in the Europe Protein A Resin market include:

• Novasep Holding SAS (U.S.)
• GE Healthcare (U.S.)
• Thermo Fisher Scientific Inc. (U.S.)
• Merck KGaA (Germany)
• JSR Corporation (Japan)
• Tosoh Corporation (Japan)
• Repligen Corporation (U.S.)
• Expedeon Ltd. (U.S.)
• GenScript (U.S.)

Players in the Europe Protein A Resin market are entering into partnerships and collaborations, launching newer products in the market to garner larger market share

KEY FEATURES OF THE REPORT:

• The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)
• The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
• The Report Outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
• The report tracks recent innovations, key developments and startup’s details that are actively working in the market
• The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
• The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

DETAILED SEGMENTATION

Product Type

• Natural Protein A Resin
• Recombinant Protein A Resin

Matrix Type

• Glass or Silica
• Agarose
• Organic Polymer

Application

• Immunoprecipitation (IP)
• Antibody Purification

End User

• Biopharmaceutical Companies
• Clinical Research Laboratories
• Academic Institutes

Country

• Germany
• France
• U.K
• Italy
• Spain
• Russia
• Poland
• Rest of Europe

Contents

1. EXECUTIVE SUMMARY

2. EUROPE PROTEIN-A RESIN MARKET INTRODUCTION

2.1. Europe Protein-A Resin Market – Taxonomy
2.2. Europe Protein-A Resin Market –Definitions
  2.2.1. Matrix Type
  2.2.2. Application type
  2.2.3. End-user

3. EUROPE PROTEIN-A RESIN MARKET DYNAMICS

3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Europe Protein-A Resin Market Dynamics – Factors Impact Analysis
3.6. Europe Protein-A Resin Market – Regulations
3.7. Europe Protein-A Resin Market – Product Innovations

4. EUROPE PROTEIN-A RESIN MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis

5. EUROPE PROTEIN-A RESIN MARKET, BY MATRIX TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023

5.1. Glass or Silica
  5.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  5.1.3. Market Opportunity Analysis
5.2. Agarose
  5.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  5.2.3. Market Opportunity Analysis
5.3. Organic Polymer
  5.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  5.3.3. Market Opportunity Analysis

6. EUROPE PROTEIN-A RESIN MARKET FORECAST, BY APPLICATION, 2012 - 2016 AND FORECAST, 2017 - 2023

6.1. Immunoprecipitation
  6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  6.1.3. Market Opportunity Analysis
6.2. Antibody purification
  6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  6.2.3. Market Opportunity Analysis

7. EUROPE PROTEIN-A RESIN MARKET FORECAST, BY END-USER, 2012 - 2016 AND FORECAST, 2017 - 2023

7.1. Hospitals Biopharmaceutical Companies
  7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  7.1.3. Market Opportunity Analysis
7.2. Clinical Research Laboratories
  7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  7.2.3. Market Opportunity Analysis
7.3. Academic Institutes
  7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  7.3.3. Market Opportunity Analysis

8. EUROPE PROTEIN-A RESIN MARKET FORECAST, BY COUNTRY, 2012 - 2016 AND FORECAST, 2017 - 2023

8.1. Germany
  8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  8.1.3. Market Opportunity Analysis
8.2. France
  8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  8.2.3. Market Opportunity Analysis
8.3. U.K
  8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  8.3.3. Market Opportunity Analysis
8.4. Italy
  8.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  8.4.3. Market Opportunity Analysis
8.5. Spain
  8.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  8.5.3. Market Opportunity Analysis
8.6. Russia
  8.6.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  8.6.3. Market Opportunity Analysis
8.7. Poland
  8.7.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  8.7.3. Market Opportunity Analysis
8.8. Rest of Europe
  8.8.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  8.8.3. Market Opportunity Analysis
8.9. Europe Protein-A Resin Market - Opportunity Analysis Index, Matrix Type, Application, End-User and Region, 2017 – 2023

9. GERMANY PROTEIN-A RESIN MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  9.1.1. Matrix Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    9.1.1.1. Glass or Silica
    9.1.1.2. Agarose
    9.1.1.3. Organic Polymer
  9.1.2. Application Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    9.1.2.1. Immunoprecipitation
    9.1.2.2. Antiboody Purification
  9.1.3. End-user Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    9.1.3.1. Biopharmaceutical Companies
    9.1.3.2. Clinical Research Laboratories
    9.1.3.3. Academic Institutes
  9.1.4. Europe Protein-A Resin Market - Opportunity Analysis Index, By Matrix Type, Application type, End-User and Country, 2017 – 2023
  9.1.5. Europe Protein-A Resin Market Dynamics – Trends

10. UK PROTEIN-A RESIN MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

11. FRANCE PROTEIN-A RESIN MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

12. SPAIN PROTEIN-A RESIN MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

13. ITALY PROTEIN-A RESIN MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

14. RUSSIA PROTEIN-A RESIN MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

15. POLAND PROTEIN-A RESIN MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

16. OTHERS PROTEIN-A RESIN MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

17. COMPETITION LANDSCAPE

17.1. Strategic Dashboard of Top Market Players
17.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
  17.2.1. Novasep Holding SAS (U.S.)
  17.2.2. GE Healthcare (U.S.)
  17.2.3. Thermo Fisher Scientific Inc. (U.S.)
  17.2.4. Merck KGaA (Germany)
  17.2.5. JSR Corporation (Japan)
  17.2.6. Tosoh Corporation (Japan)
  17.2.7. Repligen Corporation (U.S.)
  17.2.8. Expedeon Ltd. (U.S.)
  17.2.9. GenScript (U.S.)

18. RESEARCH METHODOLOGY

19. KEY ASSUMPTIONS AND ACRONYMS